Ductal adenocarcinoma of pancreas
Clinical trials for Ductal adenocarcinoma of pancreas explained in plain language.
Never miss a new study
Get alerted when new Ductal adenocarcinoma of pancreas trials appear
Sign up with your email to follow new studies for Ductal adenocarcinoma of pancreas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new injection boost chemotherapy against pancreatic cancer?
Disease control OngoingThis early-stage trial is testing an investigational drug called GKL-006, given alongside standard chemotherapy, in people with advanced pancreatic cancer that cannot be removed by surgery. The study aims to see if the combination is safe and tolerable, and whether it shows any p…
Matched conditions: DUCTAL ADENOCARCINOMA OF PANCREAS
Phase 1/2 • Sponsor: Beijing Gene Key Life Technology Co., Ltd • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New cancer drug YL201 enters human testing for advanced tumors
Disease control OngoingThis study tests an experimental drug, YL201, in about 990 people with advanced solid tumors like lung, prostate, and liver cancers. The goal is to check safety and see if tumors shrink. It is an early-stage trial, so the drug is not yet proven to work.
Matched conditions: DUCTAL ADENOCARCINOMA OF PANCREAS
Phase 1/2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC